The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
The WNT system: background and its role in bone
Abstract
WNT s are extracellular proteins that activate different cell surface receptors linked to canonical and noncanonical WNT signalling pathways. The Wnt genes were originally discovered as important for embryonic development of fruit flies and malignant transformation of mouse mammary cancers. More recently, WNT s have been implicated in a wide spectrum of biological phenomena and diseases. During the last decade, several lines of clinical and preclinical evidence have indicated that WNT signalling is critical for trabecular and cortical bone mass, and this pathway is currently an attractive target for drug development. Based on detailed knowledge of the different WNT signalling pathways, it appears that it might be possible to develop drugs that specifically target cortical and trabecular bone. Neutralization of a bone‐specific WNT inhibitor is now being evaluated as a promising anabolic treatment for patients with osteoporosis. Here, we provide the historical background to the discoveries of WNT s, describe the different WNT signalling pathways and summarize the current understanding of how these proteins regulate bone mass by affecting bone formation and resorption.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The best characterized regulators of osteogenesis include Wnt/β-catenin pathway, bone morphogenetic proteins (BMPs), runt related transcription factor-2 (Runx2), and osterix (OSX), etc. [3–7].”
From N-myc downstream regulated gene 1 suppresses osteoblast differentiation through inactivating Wnt/β-catenin signaling (2022) · cites this paper as [7]
Citations
Cites
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
Robling, A. G., Niziolek, P. J., Baldridge, L. A., Condon, K. W., Allen, M. R., Alam, I., Mantila, S. M., Gluhak-Heinrich, J., Bellido, T. M., Harris, S. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705092200 · Cited by 1,350
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201089 · Cited by 1,086
The Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
Wnt and calcium signaling: β-Catenin-independent pathways
Kohn, A. D., & Moon, R. T. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.022 · Cited by 730
SOME POSSIBLE EFFECTS OF NURSING ON THE MAMMARY GLAND TUMOR INCIDENCE IN MICE
Bittner, J. J. (1936) · Science · doi:10.1126/science.84.2172.162 · Cited by 588
Flagged first, then by citations
Research works printed but not linked: 111
- 10.1016/0012-1606(76)90108-1 · DOI
- 10.1038/287795a0 · DOI
- Korteweg R, 1936, On the manner in which the disposition to carcinoma of the mammary gland is inherited in mice, Genetics, 18, 350
- 10.1038/1941141a0 · DOI
- 10.1016/0092-8674(82)90409-3 · DOI
- 10.1016/0092-8674(87)90038-9 · DOI
- 10.1016/0092-8674(92)90630-U · DOI
- 10.1016/j.devcel.2009.06.016 · DOI · Paper page
- 10.1242/dev.033910 · DOI
- 10.1016/j.tcb.2009.01.003 · DOI
- 10.1038/nm.3074 · DOI · Paper page
- 10.1016/B978-0-12-385044-7.00007-2 · DOI
- 10.1111/j.1349-7006.2003.tb01424.x · DOI
- 10.1016/j.devcel.2006.11.003 · DOI
- 10.1038/nm.2653 · DOI · Paper page
- 10.1038/nm.3654 · DOI
- 10.1038/nm.3586 · DOI
- 10.1074/jbc.M702391200 · DOI
- 10.1038/nature756 · DOI · Paper page
- 10.1182/blood-2008-03-145169 · DOI
- Gong Y, 1996, Osteoporosis‐pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12‐13, Am J Hum Genet, 59, 146
- 10.1086/515470 · DOI
- 10.1093/hmg/7.9.1407 · DOI
- 10.1016/S0092-8674(01)00571-2 · DOI · Paper page
- 10.1086/338450 · DOI · Paper page
- 10.1086/368277 · DOI · Paper page
- 10.1136/jmg.39.2.91 · DOI · Paper page
- 10.1101/gr.3437105 · DOI · Paper page
- 10.1002/ajmg.10401 · DOI
- 10.1086/318811 · DOI · Paper page
- 10.1007/s00439-011-0947-3 · DOI
- 10.1126/science.1136370 · DOI
- 10.1359/JBMR.050101 · DOI
- 10.1186/1471-2350-13-26 · DOI
- 10.1074/jbc.M110.190330 · DOI
- 10.1056/NEJMoa1215458 · DOI
- 10.1016/j.ajhg.2013.02.010 · DOI
- 10.1016/j.bone.2014.06.041 · DOI
- 10.1016/j.ejmg.2012.06.011 · DOI
- 10.1038/ng.2249 · DOI
- 10.1210/jc.2012-1890 · DOI
- 10.1371/journal.pgen.1002745 · DOI
- 10.1002/jbmr.1796 · DOI
- 10.1007/s00198-013-2302-0 · DOI
- 10.1016/j.gene.2013.09.080 · DOI
- 10.1016/j.bone.2013.10.022 · DOI
- 10.1093/hmg/ddt675 · DOI
- 10.1371/journal.pgen.1004423 · DOI
- 10.1093/hmg/ddt575 · DOI
- 10.1016/j.gene.2011.10.044 · DOI
- 10.1038/nrendo.2013.154 · DOI
- 10.1242/dev.01117 · DOI · Paper page
- 10.1073/pnas.0133792100 · DOI · Paper page
- 10.1359/jbmr.040907 · DOI
- 10.1073/pnas.0505259102 · DOI
- 10.1359/jbmr.080512 · DOI
- 10.1371/journal.pone.0007930 · DOI
- 10.1242/dev.02696 · DOI · Paper page
- 10.1359/jbmr.2003.18.6.960 · DOI
- 10.1038/nm.2388 · DOI
- 10.1128/MCB.25.12.4946-4955.2005 · DOI
- 10.1074/jbc.M609509200 · DOI
- 10.1016/j.cell.2008.09.059 · DOI
- 10.1073/pnas.1120407109 · DOI
- 10.1016/j.gep.2008.12.009 · DOI
- 10.1136/jmedgenet-2013-101567 · DOI
- 10.1038/ncb1647 · DOI
- 10.1016/j.bbrc.2011.08.061 · DOI
- 10.1002/jcb.20284 · DOI
- 10.1182/blood-2007-10-120253 · DOI
- 10.1083/jcb.201207142 · DOI
- 10.1016/j.cellsig.2014.07.018 · DOI
- 10.1242/dev.01564 · DOI · Paper page
- 10.1371/journal.pgen.1004145 · DOI
- 10.1073/pnas.0408742102 · DOI
- 10.1359/jbmr.070810 · DOI
- 10.1074/jbc.M700030200 · DOI
- 10.1002/jbmr.118 · DOI
- 10.1359/jbmr.060810 · DOI
- 10.1093/emboj/cdg599 · DOI
- 10.1016/j.ydbio.2010.03.021 · DOI
- 10.1359/jbmr.080216 · DOI
- 10.1359/jbmr.090411 · DOI
- 10.1074/jbc.M602308200 · DOI
- 10.1002/jbmr.217 · DOI
- 10.1002/jbmr.479 · DOI
- 10.1210/jc.2009-2283 · DOI
- 10.1530/EJE-12-1074 · DOI
- 10.1007/s00198-011-1806-8 · DOI
- 10.1016/j.bone.2006.03.017 · DOI
- 10.1016/S1534-5807(01)00041-7 · DOI
- 10.1359/jbmr.060311 · DOI
- 10.1038/nrc2189 · DOI · Paper page
- 10.1016/j.devcel.2005.02.017 · DOI · Paper page
- 10.1074/jbc.M501900200 · DOI · Paper page
- 10.1128/MCB.01428-09 · DOI
- 10.1128/MCB.05980-11 · DOI
- 10.1016/j.bone.2010.11.020 · DOI
- 10.1038/nrendo.2011.207 · DOI
- 10.1359/jbmr.081206 · DOI
- 10.1359/jbmr.090403 · DOI
- 10.1002/jbmr.1984 · DOI
- 10.1002/jor.22525 · DOI
- 10.1002/jor.22636 · DOI
- 10.1002/art.37697 · DOI
- 10.2106/JBJS.K.00344 · DOI
- 10.1002/jbmr.14 · DOI
- 10.1002/jbmr.173 · DOI
- 10.1124/jpet.111.181404 · DOI
- 10.1002/jbmr.472 · DOI
- 10.1038/nm1538 · DOI
Cited by
Sorted by citations
A review of mathematical modeling of bone remodeling from a systems biology perspective
Cook, C. V., Lighty, A. M., Smith, B. J., & Ford Versypt, A. N. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1368555 · Cited by 25
Shi, X., Cen, Y., Shan, L., Tian, L., Zhu, E., Yuan, H., Li, X., Liu, Y., & Wang, B. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02714-5 · Cited by 15
Metadata
- Authors
- Lerner, U. H., & Ohlsson, C.
- Affiliations
- Centre for Bone and Arthritis Research Institute for Medicine Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2015-05-25
- Volume
- 277
- Issue
- 6
- Pages
- 630-649
- ISSN
- 0954-6820
- 1365-2796
- Cited by
- 228
- References
- 10
- Language
- en
- Funders
- Swedish Research Council
- the Swedish Foundation for Strategic Research
- COMBINE
- the ALF/LUA research grant in Gothenburg
- the Lundberg Foundation
- the Torsten and Ragnar Söderberg′s Foundation
- the Swedish Rheumatism Association
- the Royal 80 Year Fund of King Gustav V
- the Novo Nordisk Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review